Johnson & Johnson has unveiled groundbreaking findings on nipocalimab, an investigational FcRn blocker, in a recent ...

Thus, candidates should be tested against a panel of receptors at the time of antibody engineering. ACROBiosystems provides an extensive collection of recombinant Fc receptor proteins, which ...

IgM is the first antibody to be produced in a humoral immune response and plays an important role in the primary stages of immunity. Here we describe a mouse Fc receptor, designated Fcα/μR ...

HOUSE, Pa. - Johnson & Johnson (NYSE: NYSE:JNJ) has released new data on nipocalimab, an investigational drug with potential to treat diseases driven by immunoglobulin G (IgG) antibodies. Published in ...

Additionally, only a few of these antibodies specifically target the venom from the ... The now free IgGs bind to the neonatal Fc receptor (FcRn), which protects them from the cell’s “garbage disposal ...

However, evaluating the Fc receptor interaction is typically achieved ... platform to test all Fc receptors against reference antibodies. ACROBiosystems routinely applies rigorous quality control ...

Mouse anti-human immunoglobulin M (IgM) antibody δADA4-4 was obtained from the ATCC. EphrinA5-Fc was used for activating ... elements of the B-cell receptor signaling complex (BCR), CD79A ...